Techniques used to enhance bioavailability of bcs class II drugs: A review

International Journal of Drug Development and Research

Volumn 7, Issue 1, 2015, Pages 82-93

  Kansara, Honey ^a   Panola, Riddhi ^a   Mishra, Amul ^a  

^a Bhupal Nobels' Institute of Pharmaceutical Sciences   (India)

Author keywords

Amorphous state; Characterization; Dissolution enhancement; NCE

Indexed keywords

POLYMER; PRODRUG; SOLVENT; SURFACTANT;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL MODIFICATION; DIELECTRIC CONSTANT; DISPERSION; DISSOLUTION; DRUG BIOAVAILABILITY; MICELLE; PARTICLE SIZE; PRESSURE; TEMPERATURE;

EID: 84929074633     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hite, M., Federici, C., Turner, S., 2003. Part 1: Oral delivery of poorly soluble drugs. Pharmaceutical manufacturing and packaging sourcer. Issue 1 3.
2. 2) Hu, J., Johnston, K.P., WilliamsIII, R.O., 2004. Rapid dissolving high potency danazol powders produced by spray freezing into liquid process, Int. J. Pharm. 271, 145–154.
3. Lipinski, C., 2002. Poor aqueous solubility– an industry wide problem in drug delivery, Am. Pharm. Rev. 5, 82–85.
4. Dhirendra, K., Lewis, S., Udupa, N., Atin, K., 2009. Solid dispersions: A Review, Pak. J. Pharm. Sci. 22 (2), 234-246.
5. Malinowski, H.J., Bioavailability and bioequivalence testing. In: Remington: The Science and Practice of Pharmacy. In: Gennaro AR, editor. 20th ed Philadelphia: Lippincott Williams Wilkinson, 2000; 995-1004.
6. Leuner, C., Dressman, J., 2000. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50, 47–60.
7. Amidon, G.L., Lenneranas, H., Shah, V.P., Crison J.R., 1995. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. J. Pharm. Res. 12(3), 413-420.
8. Amin, K., Dannenfelser, R.M., Zielinski, J., Wang, B., 2004. Lyophilization of polyethylene glycol mixtures, J. Pharm. Sci. 93, 2244- 2249.
9. Yalkowsky, S.H., Roseman, T.J., 1981. Solubilization of drugs by cosolvents. In: Yalkowsky, S.H. Ed. Techniques of Soluhilization of Drugs. Dekker, New York.
10. Ahuja, N., Katare, O.P., Singh, B., 2007. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur. J. Pharm. Biopharm. 65, 26-38.
11. Chaumeil, J.C., 1998. Micronisation: a method of improving the bioavailability of poorly soluble drugs, Methods and Findings in Experimental and Clinical Pharmacology. 20, 211-215.
12. Babu, V.R., Areefulla, S.H., Mallikarjun, V., 2010. Solubility and Dissolution Enhancement: An overview. J Pharm Research 3(1),141- 145.
13. Bakatselou, V., Oppenheim, R.C., Dressman, J.B., 1991. Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm Res. 8, 1461-1469.
14. Challa, R., Ahuja, A., Ali, J., Khar, R.K., 2005. Cyclodextrins in Drug Delivery: An Updated Review. AAPS PharmSciTech. 6 (2), 29-57.
15. Talari, R., Varshosaz, J., Mostafavi, S.A., Nokhodchi, A., 2009. Dissolution Enhancement of Gliclazide Using pH Change Approach in Presence of Twelve Stabilizers with Various Physico-Chemical Properties. J Pharm Pharmaceut Sci. 12(3), 250 – 265.
16. Lachman, L., Lieberman, H.A., Kanig, J.L., 1990. The Theory and Practice of Industrial Pharmacy. 3rd ed. Varghese Publishing House, Bombay. 177.
17. Hussain, A., Rytting, J.H., 1974, Prodrug approach to enhancement of rate of dissolution of allopurinol. J Pharm Sci. 63 (5), 798–799.
18. Vaughn, J.M., Gao, X., Yacaman, M.J., Johnston, K.P., Williams, R.O., 2005. Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques. Eur J Pharm Biopharm. 60(1), 81-89.
19. Spireas, S., Jarowski, C.I., Rohera, D.I., 1992. Powdered solution technology: principles and mechanism. Pharm Res. 9, 1351-1368.
20. Javadzadeh, Y., Siahi-Shadbad, M.R., Barzegar Jalali, M., Nokhodchi, A., 2005. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Farmaco. 60, 361-365.
21. Nokhodchi, A., Javadzadeh, Y., Siahi- Shadbad, M.R., Barzegar-Jalali, M., 2005. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J Pharm Pharm Sci. 8,18- 25.
22. Sertsou, G., Butler, J., Scott, A., Hempenstall, J., Rades, T., 2002. Factors affecting incorporation of drug into solid solution with HPMCP during solvent change coprecipitation. Int J Pharm. 245, 99-108.
23. Gabmann, P., List, M., Schweitzer, A., Sucker, H., 1994. Hydrosols - Alternatives for the parenteral application of poorly water soluble drugs. Eur. J. Pharm. Biopharm. 40, 64–72.
24. Bertucco, A., Vetter, G., 2001. High Pressure Process Technology: Fundamentals and Applications. Industrial Chemistry Library, Elsevier, Amsterdam. 9, 1-3.
25. Chowdary, K.P.R., Madhavi, B.L.R., 2005. Novel drug delivery technologies for insoluble drugs. Indian Drugs. 42(9), 557-564.
26. Pouton, W.C., 2000. Lipid formulations for oral administration of drugs: nonemulsifying, self emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur. J. Pharm. Sci. 11(2), S93– S98.
27. O'Driscoll, C. M., 2002. Lipid based formulations for intestinal lymphatic delivery, Eur. J. Pharm. Sci. 15, 405– 415.
28. Charman, W.N., 2000. Lipids, lipophilic drugs, and oral drug delivery—some emerging concepts. J. Pharm. Sci. 89, 967–978.
29. Porter, C.J.H., Trevaskis, N.L., Charman, W.N., 2007. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs, Nature Rev. Drug Disc. 6, 231–248.
30. Dangi, J.S., Vyas, S.P., Dixit, V.K., 1998. The role of mixed micelles in drug delivery. I. Solubilization. Drug Dev.Ind.Pharm. 24, 681–684.
31. Chiou, W.L., Riegelman, S., 1971. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60(9), 1281-1302.
32. Sekiguchi, K., Obi, N., 1961. Studies on Absorption of Eutectic Mixture. I. A comparison of the behaviour of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull. 9, 866-872.
33. Breitenbach, J., 2000. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm. 54 (2), 107 - 117.
34. Mullins, J.D, Macek, T.J., 1960. Some pharmaceutical properties of novobiocin. J. Am. Pharm. Assoc. Sci. Ed., 49, 245-248.
35. Goldberg, A.H., Gibaldi, M., Kanig, J.L., 1965. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. J. Pharm. Sci. 54(8), 1145-1148.
36. Rastogi, R.P., Rama Varma, K.T., 1956. Solid-liquid equilibria in solutions of non-electrolytes. J. Chem.Soc. 2, 2097-2101.
37. Simonelli, A.P., Mehta, S.C., Higuchi, W.I., 1969. Dissolution rates of high energy polyvinylpyrrolidone (PVP)- sulfathiazole coprecipitates. J. Pharm. Sci. 58(5), 538-549.
38. Goldberg, A.H., Gibaldi, M., Kanig, L., 1966. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures II experimental evaluation of a eutectic mixture: urea-acetaminophen system. J. Pharm. Sci. 55, 482-487.
39. Chiou, W.L., Riegelman, S., 1969. Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J. Pharm. Sci. 1505-1510.